Insider · CIK 0001678516
Priebe Waldemar
Reports to the SEC for 2 companies · HOUSTON, TX
Transactions
20
Companies
2
Filings
4
CIK
0001678516
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-03-28 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$10.4K |
| 2023-03-27 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$5,450 |
| 2023-03-24 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$5,400 |
| 2023-03-23 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$10.8K |
| 2023-03-22 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$5,400 |
| 2023-03-21 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$5,500 |
| 2023-03-20 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$5,400 |
| 2023-03-17 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$5,650 |
| 2023-03-16 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$6,200 |
| 2023-03-15 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$6,100 |
| 2023-03-14 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$6,750 |
| 2023-03-13 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$6,500 |
| 2023-03-10 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$6,450 |
| 2022-12-09 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$6,799.14 |
| 2022-12-08 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$13.2K |
| 2022-12-07 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$13.5K |
| 2022-12-06 | CNSPCNS Pharmaceuticals, Inc.S Sale | −$13.6K |
| 2020-08-20 | MBRXMoleculin Biotech, Inc. · Stock option (right to buy)A Award | — |
| 2020-05-05 | CNSPCNS Pharmaceuticals, Inc.J Other | — |
| 2017-08-16 | MBRXMoleculin Biotech, Inc.S Sale | −$170K |
Recent filings
- 4Priebe Waldemar0000897069-23-001044SEC(opens sec.gov)
- 4Priebe Waldemar0001683168-22-000460SEC(opens sec.gov)
- 4Priebe Waldemar0001659617-20-000206SEC(opens sec.gov)
- 4Priebe Waldemar0001144204-17-044232SEC(opens sec.gov)
Companies
Address
C/O MOLECULIN BIOTECH, INC. 2575 WEST BELLFORT, SUITE 333
HOUSTON, TX, 77054